A medication once used only to treat breast cancer, is showing great promise for preventing it in high risk women.

H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Atossa Therapeutics (ATOS – Research Report) today and set a price target ...

But I will always have had cancer, and I will always be different than I was before. To prevent recurrence, I have to take ...

Hormone therapy (also called hormonal therapy or endocrine therapy) slows or stops the growth of hormone-sensitive tumors by blocking the body’s ability to produce hormones or by interfering with the ...

Women taking a new breast cancer drug are living longer than those taking Tamoxifen - the current 'gold standard' treatment. Doctors predict the new drug, Arimidex, will improve long-term survival ...

Switching to an AI following 2–3 years of initial adjuvant tamoxifen is an effective option for patients unable to begin treatment with an AI. This article evaluates the most up-to-date results ...

Atossa Therapeutics (ATOS) released positive topline data from the KARISMA-Endoxifen Phase 2 study of z-endoxifen in premenopausal women with ...

"In the last few years, we’ve made a lot of advancements in treatment options. Breast cancer is something that, if caught early, it’s very treatable; it’s very beatable," said Dr. Janette Gomez, a ...

Among the many impactful sessions, a symposium titled ‘Incorporating Novel Treatment Insights for Estrogen Receptor-Positive (ER+) Early Breast Cancer Patients’ garnered particular attention.

Marcy is an award-winning audio producer who has covered science, technology, history, culture, sports, business, and ...

“There were trials done and those trials showed that tamoxifen does in fact reduce the chances of developing breast cancer by almost a half for women who are at increased risk. And there was a ...